α‐lipoic acid prevents non‐alcoholic fatty liver disease in <scp>OLETF</scp> rats

Abstract

Chronic ALA supplementation prevents NAFLD through multiple mechanisms by reducing steatosis, oxidative stress, immune activation and inflammation in the liver.